1)Gupta V, Ov M, Rao A et al:Long-term structural and functional outcomes of therapy in juvenile-onset primary open-angle glaucoma. Ophthalmologica 228:19-25, 2012
2)Quaranta L, Biagioli E, Riva I et al:The Glaucoma Italian Pediatric Study(GIPSy):3-year results. J Glaucoma 27:856-863, 2018
3)Maeda-Chubachi T, Chi-Burris K, Simons B et al:Impact of age, diagnosis, and history of glaucoma surgery on outcomes in pediatric patients treated with latanoprost. J Glaucoma 22:614-619, 2013
4)Black AC, Jones S, Yanovitch TL et al:Latanoprost in pediatric glaucoma-pediatric exposure over a decade. J AAPOS 13:558-562, 2009
5)Chapter 10. Medical management of glaucoma in infants and children. Weinreb RN, Araie M, Susanna R et al(ed):Medical Treatment of Glaucoma. Consensus Series 7. World Glaucoma Association Kugler Publications, Amsterdam, The Netherlands, 267-271, 2010
6)Maeda-Chubachi T, Chi-Burris K, Simons BD et al:Comparison of latanoprost and timolol in pediatric glaucoma:a phase 3, 12-week, randomized, double-masked multicenter study. Ophthalmology 118:2014-2121, 2011
7)Chang L, Ong EL, Bunce C et al:A review of medical treatment of pediatric glaucoma at Moorfields Eye Hospital. J Glaucoma 22:601-607, 2013
8)Coppens G, Stalmans I, Zeyen T et al:The safety and efficacy of glaucoma medication in pediatric population. J Pediatric Ophthalmol Strabismus 46:12-18, 2009